|
LOC646471 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.168000E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.956800E-01 |
| Normal-vs-Stage2 |
7.755800E-01 |
| Normal-vs-Stage3 |
4.992100E-02 |
| Normal-vs-Stage4 |
2.387200E-01 |
| Stage1-vs-Stage2 |
9.983600E-01 |
| Stage1-vs-Stage3 |
1.124290E-02 |
| Stage1-vs-Stage4 |
1.969180E-01 |
| Stage2-vs-Stage3 |
7.135600E-02 |
| Stage2-vs-Stage4 |
2.715000E-01 |
| Stage3-vs-Stage4 |
6.954600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.441400E-01 |
| Normal-vs-AfricanAmerican |
8.488800E-01 |
| Normal-vs-Asian |
6.970600E-01 |
| Caucasian-vs-AfricanAmerican |
3.870600E-01 |
| Caucasian-vs-Asian |
5.779800E-01 |
| AfricanAmerican-vs-Asian |
8.051000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.649200E-01 |
| Normal-vs-Female |
3.576800E-01 |
| Male-vs-Female |
9.822200E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.834400E-01 |
| Normal-vs-Extreme_Weight |
6.276600E-01 |
| Normal-vs-Obese |
8.135000E-01 |
| Normal-vs-Extreme_Obese |
4.092000E-01 |
| Normal_Weight-vs-Extreme_Weight |
6.868000E-02 |
| Normal_Weight-vs-Obese |
1.749420E-01 |
| Normal_Weight-vs-Extreme_Obese |
2.171600E-01 |
| Extreme_Weight-vs-Obese |
7.642600E-01 |
| Extreme_Weight-vs-Extreme_Obese |
4.172400E-01 |
| Obese-vs-Extreme_Obese |
3.446400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.780600E-01 |
| Normal-vs-Age(41-60Yrs) |
5.273200E-01 |
| Normal-vs-Age(61-80Yrs) |
5.961800E-01 |
| Normal-vs-Age(81-100Yrs) |
3.237900E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.574000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.736400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.536200E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.260000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.636600E-04 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.633600E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
7.217700E-02 |
| Normal-VS-Type2 PRCC |
9.998700E-04 |
| Normal-VS-KIRP CIMP |
4.940100E-02 |
| Normal-VS-Unclassified PRCC |
6.608400E-01 |
| Type1 PRCC-VS-Type2 PRCC |
1.62458935193399E-12 |
| Type1 PRCC-VS-KIRP CIMP |
6.537000E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
1.818590E-01 |
| Type2 PRCC-VS-KIRP CIMP |
9.410200E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
6.400800E-04 |
| KIRP CIMP-VS-Unclassified PRCC |
4.816500E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.114400E-01 |
| Normal-vs-N1 |
4.024600E-04 |
| Normal-vs-N2 |
2.144400E-01 |
| N0-vs-N1 |
2.615400E-03 |
| N0-vs-N2 |
4.217600E-01 |
| N1-vs-N2 |
6.221200E-01 |
|
|
